366 related articles for article (PubMed ID: 29803280)
1. Atypical Hemolytic Uremic Syndrome.
Dixon BP; Gruppo RA
Pediatr Clin North Am; 2018 Jun; 65(3):509-525. PubMed ID: 29803280
[TBL] [Abstract][Full Text] [Related]
2. An effective treatment of atypical hemolytic uremic syndrome with plasma exchange and eculizumab: A case report.
Sengul Samanci N; Ayer M; Ergen A; Ozturk S
Transfus Apher Sci; 2015 Jun; 52(3):314-6. PubMed ID: 25634788
[TBL] [Abstract][Full Text] [Related]
3. Atypical Hemolytic-Uremic Syndrome: An Update on Pathophysiology, Diagnosis, and Treatment.
Raina R; Krishnappa V; Blaha T; Kann T; Hein W; Burke L; Bagga A
Ther Apher Dial; 2019 Feb; 23(1):4-21. PubMed ID: 30294946
[TBL] [Abstract][Full Text] [Related]
4. [Atypical hemolytic uremic syndrome].
Sepúlveda RA; Tagle R; Jara A
Rev Med Chil; 2018 Jun; 146(6):770-779. PubMed ID: 30148909
[TBL] [Abstract][Full Text] [Related]
5. Postpartum thrombotic microangiopathy revealed as atypical hemolytic uremic syndrome successfully treated with eculizumab: a case report.
Kourouklaris A; Ioannou K; Athanasiou I; Panagidou A; Demetriou K; Zavros M
J Med Case Rep; 2014 Sep; 8():307. PubMed ID: 25219386
[TBL] [Abstract][Full Text] [Related]
6. Atypical hemolytic uremic syndrome: a case report.
Basnayake BMDB; Wazil AWM; Nanayakkara N; Samarakoon SMDK; Senavirathne EMSK; Thangarajah BUEWDR; Karunasena N; Mahanama RMBSS
J Med Case Rep; 2020 Jan; 14(1):11. PubMed ID: 31928535
[TBL] [Abstract][Full Text] [Related]
7. Clinical Practice Guidelines for the Management of Atypical Hemolytic Uremic Syndrome in Korea.
Cheong HI; Jo SK; Yoon SS; Cho H; Kim JS; Kim YO; Koo JR; Park Y; Park YS; Shin JI; Yoo KH; Oh D
J Korean Med Sci; 2016 Oct; 31(10):1516-28. PubMed ID: 27550478
[TBL] [Abstract][Full Text] [Related]
8. Hemolytic uremic syndrome with dual caution in an infant: cobalamin C defect and complement dysregulation successfully treated with eculizumab.
Barlas UK; Kıhtır HS; Goknar N; Ersoy M; Akcay N; Sevketoglu E
Pediatr Nephrol; 2018 Jun; 33(6):1093-1096. PubMed ID: 29558000
[TBL] [Abstract][Full Text] [Related]
9. Use of Eculizumab in Atypical Hemolytic Uremic Syndrome, Complicating Systemic Lupus Erythematosus.
Bermea RS; Sharma N; Cohen K; Liarski VM
J Clin Rheumatol; 2016 Sep; 22(6):320-3. PubMed ID: 27556240
[TBL] [Abstract][Full Text] [Related]
10. The complex differential diagnosis between thrombotic thrombocytopenic purpura and the atypical hemolytic uremic syndrome: Laboratory weapons and their impact on treatment choice and monitoring.
Mannucci PM; Cugno M
Thromb Res; 2015 Nov; 136(5):851-4. PubMed ID: 26386489
[TBL] [Abstract][Full Text] [Related]
11. Atypical Hemolytic Uremic Syndrome: A Meta-Analysis of Case Reports Confirms the Prevalence of Genetic Mutations and the Shift of Treatment Regimens.
Krishnappa V; Gupta M; Elrifai M; Moftakhar B; Ensley MJ; Vachharajani TJ; Sethi SK; Raina R
Ther Apher Dial; 2018 Apr; 22(2):178-188. PubMed ID: 29250893
[TBL] [Abstract][Full Text] [Related]
12. [Recurrent atypical hemolytic uremic syndrome after renal transplantation: treatment with eculizumab].
Latzke AB; Fernández P; Chiurchiu C; Sarmantano D; De Arteaga J; Douthat W; De la Fuente J
Medicina (B Aires); 2018; 78(2):119-122. PubMed ID: 29659362
[TBL] [Abstract][Full Text] [Related]
13. An update for atypical haemolytic uraemic syndrome: diagnosis and treatment. A consensus document.
Campistol JM; Arias M; Ariceta G; Blasco M; Espinosa L; Espinosa M; Grinyó JM; Macía M; Mendizábal S; Praga M; Román E; Torra R; Valdés F; Vilalta R; Rodríguez de Córdoba S
Nefrologia; 2015; 35(5):421-47. PubMed ID: 26456110
[TBL] [Abstract][Full Text] [Related]
14. Atypical hemolytic uremic syndrome: Review of clinical presentation, diagnosis and management.
Sridharan M; Go RS; Willrich MAV
J Immunol Methods; 2018 Oct; 461():15-22. PubMed ID: 30031798
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of eculizumab in adult patients with atypical hemolytic uremic syndrome: A single center experience from Turkey.
Gediz F; Payzin BK; Ecemis S; Güler N; Yilmaz AF; Topcugil F; Berdeli A
Transfus Apher Sci; 2016 Dec; 55(3):357-362. PubMed ID: 27742267
[TBL] [Abstract][Full Text] [Related]
16. Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome.
Legendre CM; Licht C; Muus P; Greenbaum LA; Babu S; Bedrosian C; Bingham C; Cohen DJ; Delmas Y; Douglas K; Eitner F; Feldkamp T; Fouque D; Furman RR; Gaber O; Herthelius M; Hourmant M; Karpman D; Lebranchu Y; Mariat C; Menne J; Moulin B; Nürnberger J; Ogawa M; Remuzzi G; Richard T; Sberro-Soussan R; Severino B; Sheerin NS; Trivelli A; Zimmerhackl LB; Goodship T; Loirat C
N Engl J Med; 2013 Jun; 368(23):2169-81. PubMed ID: 23738544
[TBL] [Abstract][Full Text] [Related]
17. Atypical and secondary hemolytic uremic syndromes have a distinct presentation and no common genetic risk factors.
Le Clech A; Simon-Tillaux N; Provôt F; Delmas Y; Vieira-Martins P; Limou S; Halimi JM; Le Quintrec M; Lebourg L; Grangé S; Karras A; Ribes D; Jourde-Chiche N; Rondeau E; Frémeaux-Bacchi V; Fakhouri F
Kidney Int; 2019 Jun; 95(6):1443-1452. PubMed ID: 30982675
[TBL] [Abstract][Full Text] [Related]
18. First-line therapy in atypical hemolytic uremic syndrome: consideration on infants with a poor prognosis.
Szarvas N; Szilágyi Á; Tasic V; Nushi-Stavileci V; Sofijanova A; Gucev Z; Szabó M; Szabó A; Szeifert L; Reusz G; Rusai K; Arbeiter K; Müller T; Prohászka Z
Ital J Pediatr; 2014 Dec; 40():101. PubMed ID: 25496981
[TBL] [Abstract][Full Text] [Related]
19. Distal Angiopathy and Atypical Hemolytic Uremic Syndrome: Clinical and Functional Properties of an Anti-Factor H IgAλ Antibody.
Rigothier C; Delmas Y; Roumenina LT; Contin-Bordes C; Lepreux S; Bridoux F; Goujon JM; Bachelet T; Touchard G; Frémeaux-Bacchi V; Combe C
Am J Kidney Dis; 2015 Aug; 66(2):331-6. PubMed ID: 26015278
[TBL] [Abstract][Full Text] [Related]
20. Plasma resistant atypical hemolytic uremic syndrome associated with a CFH mutation treated with eculizumab: a case report.
Sevinc M; Basturk T; Sahutoglu T; Sakaci T; Koc Y; Ahbap E; Akgol C; Kara E; Brocklebank V; Goodship TH; Kavanagh D; Unsal A
J Med Case Rep; 2015 Apr; 9():92. PubMed ID: 25925370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
